HomeCompareMDT vs CEQP

MDT vs CEQP: Dividend Comparison 2026

MDT yields 3.31% · CEQP yields 9.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEQP wins by $119.5K in total portfolio value
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
CEQP
CEQP
● Live price
9.27%
Share price
$28.26
Annual div
$2.62
5Y div CAGR
25.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$54,802.53
Full CEQP calculator →

Portfolio growth — MDT vs CEQP

📍 CEQP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTCEQP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + CEQP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
CEQP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
CEQP
Annual income on $10K today (after 15% tax)
$788.04/yr
After 10yr DRIP, annual income (after tax)
$46,582.15/yr
At 15% tax rate, CEQP beats the other by $38,261.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + CEQP for your $10,000?

MDT: 50%CEQP: 50%
100% CEQP50/50100% MDT
Portfolio after 10yr
$114.1K
Annual income
$32,295.84/yr
Blended yield
28.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MDT right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
CEQP
Analyst Ratings
8
Buy
9
Hold
1
Sell
Consensus: Hold
Price Target
$33.00
+16.8% upside vs current
Range: $28.00 — $35.00
Altman Z
1.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
CEQP buys
12
PoliticianChamberTickerTypeAmountDate
Bill Hagerty🏛 Senate$CEQP▼ Sell$50,001 - $100,0002023-11-06
Mark Dr Green🏢 House$CEQP▼ Sell$250,001 - $500,0002020-12-10
Mark Dr Green🏢 House$CEQP▲ Buy$100,001 - $250,0002020-11-23
Mark Dr Green🏢 House$CEQP▼ Sell$100,001 - $250,0002020-10-22
Mark Dr Green🏢 House$CEQP▲ Buy$100,001 - $250,0002020-10-22
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-10-05
Mark Dr Green🏢 House$CEQP▼ Sell$100,001 - $250,0002020-09-11
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-28
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-12
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTCEQP
Forward yield3.31%9.27%
Annual dividend / share$2.84$2.62
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%25.6%
Portfolio after 10y$54.3K$173.8K
Annual income after 10y$9,789.15$54,802.53
Total dividends collected$29.9K$137.2K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$111.45$33.00

Year-by-year: MDT vs CEQP ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrCEQP PortfolioCEQP Income/yrGap
1← crossover$11,128$428.29$11,864$1,164.44$736.00CEQP
2$12,483$575.94$14,317$1,621.71$1.8KCEQP
3$14,138$780.71$17,616$2,297.06$3.5KCEQP
4$16,196$1,068.46$22,167$3,317.73$6.0KCEQP
5$18,809$1,479.09$28,619$4,900.54$9.8KCEQP
6$22,201$2,075.70$38,049$7,426.80$15.8KCEQP
7$26,716$2,960.69$52,303$11,590.39$25.6KCEQP
8$32,891$4,305.30$74,666$18,701.89$41.8KCEQP
9$41,599$6,405.16$111,232$31,339.23$69.6KCEQP
10$54,300$9,789.15$173,821$54,802.53$119.5KCEQP

MDT vs CEQP: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

CEQPStock

Crestwood Equity Partners LP develops, acquires, owns, controls, and operates assets and operations in the energy midstream sector in the United States. It operates through three segments: Gathering and Processing North; Gathering and Processing South; and Storage and Logistics. The Gathering and Processing North segment offers natural gas, crude oil, and produced water gathering, compression, treating, processing, and disposal services to producers in the Williston Basin and Powder River Basin. This segment owns and operates natural gas facilities with approximately 0.4 Bcf/d of gathering capacity and 0.5 Bcf/d of processing capacity; crude oil facilities with approximately 150,000 Bbls/d of gathering capacity and 266,000 Bbls of storage capacity; and produced water facilities with approximately 130,000 Bbls/d of gathering and disposal capacity. The Gathering and Processing South segment provides natural gas gathering, compression, treating, and processing; and produced water gathering and disposal services to producers in the Marcellus, Barnett, and Delaware basins. This segment owns and operates natural gas facilities with 2.5 Bcf/d of gathering capacity and 0.7 Bcf/d of processing capacity; and produced water facilities with approximately 75,000 Bbls/d of gathering and disposal capacity. The Storage and Logistics segment offers natural gas liquids, crude oil, and natural gas storage, terminal, marketing, and transportation, including rail, truck and pipeline services to producers, refiners, marketers, utilities, and other customers. Crestwood Equity GP LLC serves as the general partner of Crestwood Equity Partners LP. The company was formerly known as Inergy L.P. and changed its name to Crestwood Equity Partners LP in October 2013. Crestwood Equity Partners LP was incorporated in 2001 and is headquartered in Houston, Texas.

Full CEQP Calculator →
📬

Get this MDT vs CEQP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.